Technology Journal Nepal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal Nepal.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 5, 2025

December 5, 2025

Apeiron Therapeutics Presents First-in-Human Data from Phase 1 Clinical Trial of GTA182 in MTAP-Deleted Advanced Non-Small Cell Lung Cancer at the ESMO Asia Congress 2025

GlobeNewswire

December 5, 2025

M365Con.net Announces Deep Dive Microsoft Convention — Featuring New Sponsor xSP

GlobeNewswire

December 5, 2025

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

GlobeNewswire

December 5, 2025

ApexPoint LLC Unveils New AI-Powered Investment Platform Designed to Enhance Trading Efficiency Across Global Financial Markets

GlobeNewswire

December 5, 2025

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

GlobeNewswire

December 5, 2025

Dan Herbatschek, CEO of Ramsey Theory Group, Issues Results of New Logistics Providers Customer Survey Identifying Top AI Cyber Threats This Holiday Shipping Season

GlobeNewswire

December 5, 2025

Cycurion, Inc. (NASDAQ: CYCU) Announces $500,000 Common Share Dividend to Be Paid to its Shareholders on or about December 30th

GlobeNewswire

December 5, 2025

Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025

GlobeNewswire

December 5, 2025

Accendatech US comments on the recent setback in phase 2 study to evaluate STAT3 as therapeutic target and other drug development strategies such as AI and precision medicine to treat patients with IPF

GlobeNewswire

December 5, 2025

Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting

GlobeNewswire

December 5, 2025

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

GlobeNewswire

December 5, 2025

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures

GlobeNewswire

December 5, 2025

Paribu has acquired CoinMENA, MENA’s largest local crypto exchange, in a transaction valued at up to USD 240 million

GlobeNewswire

December 5, 2025

Strategic Partnership with Leading UAE Family Office to Build a New Growth Engine in the Middle East and North Africa

GlobeNewswire

December 5, 2025

Entro Security Leads Shai Hulud 2.0 Response with Deep Secrets Analysis and Free Exposure Checker

GlobeNewswire

December 5, 2025

Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad

GlobeNewswire

December 5, 2025

New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer

GlobeNewswire

December 5, 2025

Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum

GlobeNewswire

December 5, 2025

XBP Global Holdings, Inc. Announces 1-for-10 Reverse Stock Split

GlobeNewswire

December 5, 2025

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

GlobeNewswire